Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 10, 2021

SELL
$79.17 - $111.47 $20.2 Million - $28.4 Million
-255,147 Closed
0 $0
Q3 2020

Oct 21, 2020

SELL
$81.91 - $134.94 $12.5 Million - $20.6 Million
-152,942 Reduced 37.48%
255,147 $26.4 Million
Q2 2020

Aug 10, 2020

SELL
$54.33 - $89.52 $5.97 Million - $9.84 Million
-109,953 Reduced 21.22%
408,089 $32.3 Million
Q1 2020

May 13, 2020

SELL
$49.34 - $68.76 $1.03 Million - $1.44 Million
-20,875 Reduced 3.87%
518,042 $30 Million
Q4 2019

Feb 18, 2020

BUY
$51.21 - $59.06 $1.74 Million - $2.01 Million
34,074 Added 6.75%
538,917 $29.1 Million
Q3 2019

Nov 13, 2019

SELL
$40.6 - $57.2 $8.34 Million - $11.7 Million
-205,408 Reduced 28.92%
504,843 $26.4 Million
Q2 2019

Aug 13, 2019

BUY
$39.92 - $53.86 $6.8 Million - $9.17 Million
170,268 Added 31.53%
710,251 $34.3 Million
Q1 2019

May 14, 2019

SELL
$48.23 - $66.16 $11.9 Million - $16.3 Million
-247,043 Reduced 31.39%
539,983 $27.3 Million
Q4 2018

Feb 12, 2019

SELL
$55.63 - $73.24 $17.3 Million - $22.7 Million
-310,421 Reduced 28.29%
787,026 $46.1 Million
Q3 2018

Nov 13, 2018

SELL
$52.05 - $66.51 $17.6 Million - $22.5 Million
-337,882 Reduced 23.54%
1,097,447 $72.2 Million
Q2 2018

Aug 09, 2018

SELL
$48.33 - $55.64 $3.33 Million - $3.84 Million
-68,969 Reduced 4.58%
1,435,329 $72.5 Million
Q1 2018

May 15, 2018

SELL
$44.44 - $54.39 $11.5 Million - $14.1 Million
-259,199 Reduced 14.7%
1,504,298 $79.2 Million
Q4 2017

Feb 12, 2018

BUY
$37.77 - $47.75 $2.53 Million - $3.19 Million
66,909 Added 3.94%
1,763,497 $82 Million
Q3 2017

Nov 14, 2017

BUY
$34.14 - $40.45 $57.9 Million - $68.6 Million
1,696,588
1,696,588 $68.6 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $442M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.